A1164
Sigma
Azaserine
50x, Hybri-Max™, lyophilized powder, γ-irradiated, hybridoma tested
| Synonym: | O-Diazoacetyl- |
| CAS Number: | 115-02-6 |
| Linear Formula: | C5H7N3O4 |
| Molecular Weight: | 173.13 |
| Beilstein Registry Number: | 1726602 |
| EC Number: | 204-061-6 |
| MDL number: | MFCD00036802 |
| PubChem Substance ID: | 24890511 |
Description
| Reconstitution | Reconstitute contents of vial with 10 mL sterile cell culture medium. Stock solution is sufficient to prepare 500 mL medium. Final working concentration: 5.7 μM azaserine. |
| Legal Information | Hybri-Max is a trademark of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co. |
Properties
| grade | Hybri-Max™ |
| sterility | γ-irradiated |
| form | lyophilized powder |
| total impurities | Endotoxin, tested |
| suitability | hybridoma tested |
| storage temp. | −20°C |
Safety
| Personal Protective Equipment | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
| Hazard Codes | T |
| Risk Statements | 25-40 |
| Safety Statements | 53-36/37/39-45 |
| RIDADR | UN3462 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | VT9625000 |
References
| Merck | Merck 13,902 |







